AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.48 Million EUR | 7.22% |
| 2022 | 8.84 Million EUR | 7.15% |
| 2021 | 8.25 Million EUR | 12.41% |
| 2020 | 7.34 Million EUR | 3.7% |
| 2019 | 7.08 Million EUR | -0.38% |
| 2018 | 7.1 Million EUR | -4.1% |
| 2017 | 7.41 Million EUR | -14.61% |
| 2016 | 8.68 Million EUR | -1.58% |
| 2015 | 8.82 Million EUR | -9.01% |
| 2014 | 9.69 Million EUR | 96.89% |
| 2013 | 4.92 Million EUR | -7.23% |
| 2012 | 5.3 Million EUR | -5.26% |
| 2011 | 5.6 Million EUR | 11.8% |
| 2010 | 5.01 Million EUR | 0.31% |
| 2009 | 4.99 Million EUR | -41.97% |
| 2008 | 8.6 Million EUR | 0.21% |
| 2007 | 8.59 Million EUR | 9.85% |
| 2006 | 7.82 Million EUR | 170.61% |
| 2005 | 2.89 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 8.92 Million EUR | -0.86% |
| 2024 Q1 | 9 Million EUR | -5.05% |
| 2023 Q1 | 8.64 Million EUR | -2.3% |
| 2023 Q4 | 9.48 Million EUR | -4.29% |
| 2023 Q2 | 9.73 Million EUR | 12.63% |
| 2023 FY | 9.48 Million EUR | 7.22% |
| 2023 Q3 | 9.91 Million EUR | 1.8% |
| 2022 Q4 | 8.84 Million EUR | 6.94% |
| 2022 Q2 | 8.37 Million EUR | -1.87% |
| 2022 Q3 | 8.27 Million EUR | -1.21% |
| 2022 Q1 | 8.53 Million EUR | 3.36% |
| 2022 FY | 8.84 Million EUR | 7.15% |
| 2021 Q3 | 7.79 Million EUR | 1.81% |
| 2021 Q4 | 8.25 Million EUR | 5.93% |
| 2021 FY | 8.25 Million EUR | 12.41% |
| 2021 Q1 | 7.64 Million EUR | 4.06% |
| 2021 Q2 | 7.65 Million EUR | 0.17% |
| 2020 Q3 | 6.99 Million EUR | -1.41% |
| 2020 FY | 7.34 Million EUR | 3.7% |
| 2020 Q1 | 7.14 Million EUR | 0.85% |
| 2020 Q2 | 7.09 Million EUR | -0.66% |
| 2020 Q4 | 7.34 Million EUR | 4.98% |
| 2019 Q2 | 6.89 Million EUR | -1.96% |
| 2019 FY | 7.08 Million EUR | -0.38% |
| 2019 Q3 | 6.96 Million EUR | 0.98% |
| 2019 Q1 | 7.03 Million EUR | -1.11% |
| 2019 Q4 | 7.08 Million EUR | 1.76% |
| 2018 Q1 | 6.99 Million EUR | -5.67% |
| 2018 FY | 7.1 Million EUR | -4.1% |
| 2018 Q4 | 7.1 Million EUR | 2.19% |
| 2018 Q3 | 6.95 Million EUR | -4.94% |
| 2018 Q2 | 7.31 Million EUR | 4.65% |
| 2017 FY | 7.41 Million EUR | -14.61% |
| 2017 Q4 | 7.41 Million EUR | 2.18% |
| 2017 Q3 | 7.25 Million EUR | -3.83% |
| 2017 Q2 | 7.54 Million EUR | -4.3% |
| 2017 Q1 | 7.88 Million EUR | -9.19% |
| 2016 Q1 | 8.91 Million EUR | 1.05% |
| 2016 FY | 8.68 Million EUR | -1.58% |
| 2016 Q4 | 8.68 Million EUR | -2.7% |
| 2016 Q3 | 8.92 Million EUR | 0.85% |
| 2016 Q2 | 8.84 Million EUR | -0.75% |
| 2015 Q1 | 9.52 Million EUR | -1.71% |
| 2015 FY | 8.82 Million EUR | -9.01% |
| 2015 Q3 | 9.32 Million EUR | -1.51% |
| 2015 Q4 | 8.82 Million EUR | -5.39% |
| 2015 Q2 | 9.46 Million EUR | -0.65% |
| 2014 Q3 | 5.05 Million EUR | 1.3% |
| 2014 Q4 | 9.69 Million EUR | 91.64% |
| 2014 FY | 9.69 Million EUR | 96.89% |
| 2014 Q1 | 5.04 Million EUR | 2.5% |
| 2014 Q2 | 4.99 Million EUR | -1.05% |
| 2013 Q1 | 5.07 Million EUR | -4.33% |
| 2013 Q4 | 4.92 Million EUR | 7.27% |
| 2013 FY | 4.92 Million EUR | -7.23% |
| 2013 Q3 | 4.59 Million EUR | -5.98% |
| 2013 Q2 | 4.88 Million EUR | -3.86% |
| 2012 Q2 | 5.29 Million EUR | -5.86% |
| 2012 Q3 | 5.3 Million EUR | 0.19% |
| 2012 Q4 | 5.3 Million EUR | 0.06% |
| 2012 FY | 5.3 Million EUR | -5.26% |
| 2012 Q1 | 5.62 Million EUR | 0.38% |
| 2011 Q2 | 5.49 Million EUR | 8.65% |
| 2011 Q3 | 5.29 Million EUR | -3.66% |
| 2011 FY | 5.6 Million EUR | 11.8% |
| 2011 Q4 | 5.6 Million EUR | 5.91% |
| 2011 Q1 | 5.05 Million EUR | 0.84% |
| 2010 FY | 5.01 Million EUR | 0.31% |
| 2010 Q1 | 4.93 Million EUR | -1.2% |
| 2010 Q4 | 5.01 Million EUR | 3.04% |
| 2010 Q3 | 4.86 Million EUR | 5.6% |
| 2010 Q2 | 4.6 Million EUR | -6.69% |
| 2009 FY | 4.99 Million EUR | -41.97% |
| 2009 Q4 | 4.99 Million EUR | 0.0% |
| 2008 FY | 8.6 Million EUR | 0.21% |
| 2007 FY | 8.59 Million EUR | 9.85% |
| 2006 FY | 7.82 Million EUR | 170.61% |
| 2005 FY | 2.89 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|